Tech Company Financing Transactions

Trevena Funding Round

On 3/5/2008, Trevena landed $24 million in Series A funding from Alta Partners, HealthCare Ventures and New Enterprise Associates.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

1018 West 8th Ave. A
King of Prussia, PA 19406
USA

Phone

(610) 354-8840

Website

www.trevenainc.com

Email Address

[email protected]

Overview

Trevena (NASDAQ: TRVN) is a drug discovery company focused on developing pharmaceutical products targeting G-protein coupled receptors (GPCRs).

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Maxine Gowen

        

Chief Financial Officer

Roberto Cuca

        

Chief Scientific Officer

Michael Lark

        

VP - Bus. Development

David Soergel

        

VP - General Counsel

John Limongelli

        

Browse more venture capital transactions:

Prev: 3/5/2008: Mint Software venture capital transaction
Next: 3/5/2008: Laszlo Systems venture capital transaction

Share this article

About Database of VC Transactions

We document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary